Research brokerages are projecting salesforce.com, inc. (NYSE:CRM) to grow at an accelerated rate over the next 5 years. Wall Street analysts are looking for the company to grow 20.91% over the next year and 18.32% over the next five years.
Stock analysis may be used to determine which shares the investor should buy, and at what price they should buy. Many investors will search for stocks that are currently undervalued. Fundamental research may involve scouring the balance sheet to spot a solid company. Many investors will use financial ratios to help determine which shares to purchase. Some of the more popular ratios are return on equity, earnings per share, price to earnings, and dividend yield. Applying the same type of research across the board may help the investor spot stocks that present a good opportunity for future growth.
salesforce.com, inc.’s trailing 12- months EPS is -0.17. Last year, their EPS growth was -89.60% and their EPS growth over the past five years was 18.80%.
Let’s start off by taking a look at how the stock has been performing recently. Over the past twelve months, salesforce.com, inc. (NYSE:CRM)’s stock was 15.65%. Last week, it was -6.09%, 20.86% over the last quarter, and 3.28% for the past half-year.
Over the past 50 days, salesforce.com, inc. stock was -8.29% off of the high and 16.07% removed from the low. Their 52-Week High and Low are noted here. -8.29% (High), 61.34%, (Low).
salesforce.com, inc. (NYSE:CRM)’s performance this year to date is 15.65%. The stock has performed -6.09% over the last seven days, 5.31% over the last thirty, and 20.86% over the last three months. Over the last six months, salesforce.com, inc.’s stock has been 3.28% and 19.70% for the year.
Stock market reversals can occur at any time. When these corrections happen, the investing world may be quick to make over the top predictions. Looking at the current health of the overall stock market, it is important to remember that market corrections can be quite normal in bull market runs. Investors may use a down day to buy some names they may have had their eye on. As we near the next earnings season, everyone will be checking to see how companies have performed over the previous quarter. Investors and analysts will both be eagerly watching to see if the company can meet and beet projections.
Wall Street analysts are have a consensus analyst recommendation of 1.80 on the stock. This is based on a 1-5 scale where 1 represents a Strong Buy and 5 a Strong Sell. Brokerages covering the name have a $200.14 on the stock.
When certain portfolio stocks are performing poorly, investors may be prone to chase higher return stocks or move into safer stocks. As most investors know, short-term results have the ability to be somewhat misleading. Deviating from a well-crafted plan based on short-term market fluctuations can lead to portfolio trouble in the future. Having the proper mix of stocks in the portfolio may also be beneficial to longer-term performance. Pinpointing overall investment goals and regularly reviewing portfolio positions can help the investor stay on track.
The advice provided on this website is general advice only. It has been prepared without taking into account your objectives, financial situation or needs. Before acting on this advice you should consider the appropriateness of the advice, having regard to your own objectives, financial situation and needs. Where quoted, past performance is not indicative of future performance.